Bookmark and Share
BioAssay: AID 624042

Activators of the GIRK family of Potassium Channels (GIRK1/2_PTX_Treated_CRC)

GIRK potassium channels are a family of inward-rectifying potassium channels also known as the Kir3 family. They are expressed as homo and heterotetramers in with specific subunit combinations expressed in different brain regions and peripheral organ systems notably including the heart. Multiple lines of evidence support important roles for GIRK in a variety of physiological processes including more ..
_
   
 Tested Compounds
 Tested Compounds
All(4)
 
 
Active(4)
 
 
 Tested Substances
 Tested Substances
All(4)
 
 
Active(4)
 
 
AID: 624042
Data Source: Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters (rmGlu8_hGIRK1/2_PTX (GIRK1/2_PTX_Treated_CRC))
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
BioAssay Version:
Deposit Date: 2012-04-10
Hold-until Date: 2013-04-09
Modify Date: 2013-04-10

Data Table ( Complete ):           View Active Data    View All Data
Targets
Sequence: GIRK 1
Description ..   
Protein Family: Inward rectifier potassium channel

Gene:KCNJ3     Related Protein 3D Structures     More BioActivity Data..


more...  
BioActive Compounds: 4
Related Experiments
Show more
AIDNameTypeProbeComment
488969Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary ScreeningScreening depositor-specified cross reference: mGlu8 Primary Screening Assay
504480Assay for HTS of Gi/Go-linked GPCRs using mGluR8: SummarySummary depositor-specified cross reference: mGlu8 Summary Assay
623868Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen)Other depositor-specified cross reference: mGlu8_nonGIRK_Counterscreen
623869Development of Subtype-specific Activators of the GIRK family of Potassium Channels (rmGlu8_Gqi9_Counterscreen)Other depositor-specified cross reference: rmGlu8_Gqi9_Counterscreen
623909Activators of the GIRK family of Potassium Channels (GIRK_Confirmatory_CRC)Confirmatory depositor-specified cross reference: rmGlu8_hGIRK1/2_CRC (GIRK_Confirmatory_CRC) - Dry powder reorder
623911Activators of the GIRK family of Potassium Channels (GIRK1/2_Confirmatory)Other depositor-specified cross reference: hGIRK1/2_mGlu8_WaveformData (GIRK1/2_Confirmatory)
623932ML297 Competition in Radioligand Binding assays (Ricerca)Other depositor-specified cross reference: ML297 Competition in Radioligand Binding assays (Ricerca)
623952Activators of the GIRK family of Potassium Channels (minus_mGlu8_GIRK_Confirmatory_CRC)Confirmatory depositor-specified cross reference: hGIRK_1/2_Thallium_Flux_minus_mGlu8 - Dry powder reorder
623974Activators of the GIRK family of Potassium Channels (GIRK2/3_Confirmatory_EP)Confirmatory depositor-specified cross reference: human_GIRK2/3_Voltage_clamp (GIRK2/3_Confirmatory_EP)
623975Activators of the GIRK family of Potassium Channels (GIRK1/4_ThalliumFlux_CRC)Confirmatory depositor-specified cross reference: human_GIRK1/4_ThalliumFlux (GIRK1/4_ThalliumFlux_CRC)
623976Activators of the GIRK family of Potassium Channels (GIRK_1_4_Confirmatory_EP)Confirmatory1 depositor-specified cross reference: human_GIRK1/4_Voltage_clamp (GIRK1_4_Confirmatory_EP)
623977Activators of the GIRK family of Potassium Channels (GIRK_1_2_Confirmatory_EP)Confirmatory1 depositor-specified cross reference: human_GIRK1/2_Voltage_clamp (GIRK1_2_Confirmatory_EP)
623983Activators of the GIRK family of Potassium Channels (GIRK2/3_ThalliumFlux_CRC)Confirmatory depositor-specified cross reference: human_GIRK2/3_ThalliumFlux (GIRK2_3_ThalliumFlux_CRC)
623984Activators of the GIRK family of Potassium Channels (hKir2.1_ThalliumFlux_CRC)Confirmatory depositor-specified cross reference: human_Kir2.1_ThalliumFlux (hKir2.1_ThalliumFlux_CRC)
623986Activators of the GIRK family of Potassium Channels (hKV7.4_ThalliumFlux_CRC)Confirmatory depositor-specified cross reference: human_KV7.4_ThalliumFlux (hKV7.4_ThalliumFlux_CRC)
623988Activators of the GIRK family of Potassium Channels (hERG_ThalliumFlux_CRC)Confirmatory depositor-specified cross reference: human_hERG_kV11.1_ThalliumFlux (hERG_ThalliumFlux_CRC)
Description:
BACKGROUND:
GIRK potassium channels are a family of inward-rectifying potassium channels also known as the Kir3 family. They are expressed as homo and heterotetramers in with specific subunit combinations expressed in different brain regions and peripheral organ systems notably including the heart. Multiple lines of evidence support important roles for GIRK in a variety of physiological processes including the control of heart rate and electrical excitability in a variety of neuronal populations. Data concerning GIRK's role in neurons suggest GIRK as a potential target for a variety of therapeutic indications including pain, epilepsy, and reward/addiction. However, a complete lack of selective and effective GIRK activators has prevented any further target validation for the many indications where GIRK activation is speculated to be of potential benefit. And, although GIRK small molecule GIRK inhibitors are known, their lack of selectivity limits their utility as research tools or potential therapeutics for such indications as atrial fibrillation.

PURPOSE:
The purpose of this assay was to determine whether putative GIRK activators were still effective when G-protein coupling has been disrupted using Bordetella pertussis toxin (PTX).

REFERENCES:
1. Niswender CM, Myers KA, Lou Q, Ayala J, Kim C, Conn PJ, Weaver CD. (2008) Development of a Novel and Direct Assay for High-Throughput Screening of Gi/o-linked GPCRs using Thallium Flux Through GIRK Channels. J. Mol Pharm, 73(4):1213-24.
Protocol
High-throughput Screening:
Four, structurally distinct compounds that showed concentration-dependent efficacy when tested in AID 623909 were selected for further testing. These four compounds (PubChem SIDs: 849688, 4244565, 4258786, 22410373) were serially diluted and transferred to daughter plates as described in AID 623909. Twenty-thousand HEK-293 cells/well stably transfected with rmGlu8 and hGIRK 1/2 were plated into 384-well, black-walled, clear-bottom, poly-D-lysine coated plates in 20 uL/well Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% (v/v) dialyzed fetal bovine serum and 400 ng/ml PTX. The PTX-treated cells plates were incubated overnight in a 5% CO2 incubator at 37 degrees C. Cell culture medium was removed from cell plates using a BioTek ELx405 cell washer and replaced with 20 uL/well Assay Buffer. Twenty uL/well of 0.5 mM FluoZin-2 AM in Assay Buffer was added to cell plates using a Thermo Fisher Combi. Cell plates were incubated for ~60 min at room temperature and then the FluoZin-2 solution was removed from cell plates using the BioTek ELx405 cell washer and replaced with 20 uL/well Assay Buffer. Dye loaded and washed cell plates were transferred to a Hamamatsu FDSS 6000 and a double-addition protocol was initiated. After 10 seconds, 20 uL/well of 20 mM test compound in 0.2% DMSO and Assay Buffer was added. After 4 minutes 10 uL/well of a 5x sodium bicarbonate-based thallium stimulus buffer (20 mM HEPES pH 7.4, 135 mM NaHCO3, 2 mM CaSO4, 1 mM MgSO4, 5 mM glucose, 12 mM Tl2SO4) containing and EC20 concentration of glutamate was added and 2 more minutes of data collection followed. Fluorescence data were collected at 1 Hz.
Data Analysis.
Waveform signals (fluorescence intensity versus time normalized by dividing each fluorescence value (F) by the initial fluorescence value for each trace (F0)) were reduced to single values by subtracting the average normalized waveform from vehicle control wells from each wave on the plate followed by obtaining the slope of the change in fluorescence immediately after the addition of the thallium stimulus. Slope values were normalized as a percentage of the slope obtained by the addition of a maximally effective concentration of compound, SID 4258786. Curve fits were attempted for normalized slope values using a four-parameter logistic equation.
Comment
Compounds that demonstrated concentration-dependent efficacy in the presence of PTX were considered as candidates for further development as GIRK activator probes.
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1POTENCY_uM*Potency value in micromolarFloatμM
2POTENCY_UCI_uMPotency Upper Confidence Limit in micromolarFloatμM
3POTENCY_LCI_uMPotency Lower Confidence Limit in micromolarFloatμM
4TOPCalculated value for the Top curve fit parameterFloat
5TOP_UCLUpper Confidence limit for Top curve fit parameterFloat
6TOP_LCLLower Confidence limit for Top curve fit parameterFloat
7BOTTOMCalculated value for the Bottom curve fit parameterFloat
8BOTTOM_UCIUpper Confidence limit for Bottom curve fit parameterFloat
9BOTTOM_LCILower Confidence limit for Bottom curve fit parameterFloat
10SLOPESlope values normalized as percentage of the slope obtained by addition of maximally effective concentration of glutamateFloat
11SLOPE_UCISlope Upper Confidence limitFloat
12SLOPE_LCISlope Lower Confidence limit Float
13R1_0.0005_uM (0.0005μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
14R1_0.0015_uM (0.0015μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
15R1_0.0046_uM (0.0046μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
16R1_0.0137_uM (0.0137μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
17R1_0.0412_uM (0.0412μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
18R1_0.1235_uM (0.1235μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
19R1_0.3704_uM (0.3704μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
20R1_1.11_uM (1.11μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
21R1_3.33_uM (3.33μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
22R1_10.0_uM (10μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float
23R1_30.0_uM (30μM**)Fluorescence intensity normalized to baseline at concentration for R1 replicate (see Protocol)Float

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: 1 R03 MH076398

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: